跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Retaclav-R
Approved
STANDARD
Retaclav-R
Indchemie Health Specialties Private Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e1c28e919ce71fe
Company
Indchemie Health Specialties Private Limited
Type
Standard
Approval Details
Approval Id
9e1c28e919ce71fe
Drug Approval Philippines Name
Retaclav-R
Product Name
Retaclav-R
Registration Number
DRP-10904-04
Brand Name
Retaclav-R
Generic Name
Co-Amoxiclav
Dosage Form
Film-Coated Tablet
Dosage Strength
1 g
Manufacturer
Indchemie Health Specialties Private Limited
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Reta Drug
Issuance Date
24 June 2024
Expiry Date
17 December 2026
Pharmacologic Category
Antibacterial (Beta-Lactam Inhibitor)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e1c28e919ce71fe
Type
Standard
Back to Philippines FDA Approvals
Retaclav-R - Philippines FDA Drug Approval Details